US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROGENE INC

12.02

+0.53004.61%

Volume:208.11K

Turnover:2.56M

Market Cap:171.43M

PE:-2.81

High:13.09

Open:11.27

Low:11.27

Close:11.49

Loading ...

Overview Company News Filings

BRIEF-Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold

Neurogene Inc - Amends Agreement With Baker Bros to Increase Nomination Threshold - SEC Filing

THOMSON REUTERS

Neurogene : Increases Nomination Threshold at Which Bba Has Certain Rights to Nominate One Person as Director to 14.9% of Voting Stock

THOMSON REUTERS

Neurogene Is Maintained at Outperform by BMO Capital

Neurogene announces peer-reviewed publication of EXACT transgene technology

Biotech stocks slide as Marks resignation seen being negative for sector

Neurogene files $300M mixed securities shelf

Neurogene price target lowered to $38 from $46 at Baird

Neurogene Is Maintained at Buy by HC Wainwright & Co.

Neurogene Inc reports results for the quarter ended December 31 - Earnings Summary

Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY

BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing

Neurogene Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

THOMSON REUTERS

BRIEF-Neurogene FY Net Income USD -75.144 Million

Neurogene Inc - Regulatory Update on Ngn-401 Trial Plans Expected in H1 2025

THOMSON REUTERS

Neurogene Inc: Cash Runway Into Second Half of 2027

THOMSON REUTERS

Neurogene FY Operating Income USD -82.605 Million

THOMSON REUTERS

Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates

THOMSON REUTERS

Press Release: Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NGNE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGNE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":12.02,"timestamp":1745265600000,"preClose":11.49,"halted":0,"volume":208113,"delay":0,"floatShares":4877966,"shares":14262066,"eps":-4.28,"marketStatus":"Pre-Mkt","change":0.53,"latestTime":"04-22 04:23:06 EDT","open":11.27,"high":13.09,"low":11.27,"amount":2557312.730961,"amplitude":0.158399,"askPrice":14.47,"askSize":100,"bidPrice":9.71,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.28,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":12.02,"postHourTrading":{"tag":"盘后","latestPrice":11.42,"preClose":12.02,"latestTime":"17:33 EDT","volume":550,"amount":6544.96,"timestamp":1745271184616},"volumeRatio":0.747441581654189,"impliedVol":1.2109,"impliedVolPercentile":0.8655},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","floatShares":4877966,"roa":"-18.49%","roe":"-30.28%","lyrEps":-4.277545,"volumeRatio":0.747441581654189,"shares":14262066,"dividePrice":0,"high":13.09,"amplitude":0.158399,"preClose":11.49,"low":11.27,"week52Low":6.875,"pbRate":"0.55","psRate":"185.33","week52High":74.49,"institutionHeld":0,"latestPrice":12.02,"eps":-4.28,"divideRate":0,"volume":208113,"delay":0,"ttmEps":-4.28,"open":11.27,"prevYearClose":22.86,"prevWeekClose":11.49,"prevMonthClose":11.71,"prevQuarterClose":11.71,"fiveDayClose":11,"twentyDayClose":14.21,"sixtyDayClose":15.58},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGNE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527409921","title":"BRIEF-Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2527409921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527409921?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:35","pubTimestamp":1744666531,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold April 14  - Neurogene Inc NGNE.O:NEUROGENE INC - AMENDS AGREEMENT WITH BAKER BROS TO INCREASE NOMINATION THRESHOLD - SEC FILINGNEUROGENE : INCREASES NOMINATION THRESHOLD AT WHICH BBA HAS CERTAIN RIGHTS TO NOMINATE ONE PERSON AS DIRECTOR TO 14.9% OF VOTING STOCKFurther company coverage: NGNE.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS26F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2527614495","title":"Neurogene Inc - Amends Agreement With Baker Bros to Increase Nomination Threshold - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527614495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527614495?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:52","pubTimestamp":1744663956,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS26F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2527144467","title":"Neurogene : Increases Nomination Threshold at Which Bba Has Certain Rights to Nominate One Person as Director to 14.9% of Voting Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2527144467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527144467?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:52","pubTimestamp":1744663956,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS26F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2527152998","title":"Neurogene Is Maintained at Outperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2527152998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527152998?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:08","pubTimestamp":1744632480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NGNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 08:08 ET (12:08 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMO","NGNE"],"gpt_icon":0},{"id":"2524446541","title":"Neurogene announces peer-reviewed publication of EXACT transgene technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2524446541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524446541?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:06","pubTimestamp":1743624400,"startTime":"0","endTime":"0","summary":"The company states: “Neurogene (NGNE) announced a peer-reviewed publication on its EXACT transgene regulation technology. The preclinical studies d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-announces-peer-reviewed-publication-of-exact-transgene-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-announces-peer-reviewed-publication-of-exact-transgene-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","BK4568","LU1430594728.SGD","BK4578","SRPT","IE0009355771.USD","IE00BZ9MQY76.HKD","RGNX","GLPG","LU1066051498.USD","LU2462157665.USD","LU1066053197.SGD","PTCT","TSHA","LU0823416689.USD","IE00B3T34201.USD","BK4007","NGNE","LU0320765992.SGD","RCKTW","LU1571399168.USD","REGN","FDMT","BK4139","RNA","IE00BFTCPJ56.SGD","DTIL","BEAM","VERV","LU2468319806.SGD","LU1069344957.HKD","MGTX","PCRX","LU1035775433.USD","LU0417517546.SGD","MRNA","LU0058720904.USD","PRME","VRTX","RCKT","LU2023250504.SGD","DYN","BK4532","LEGN","KPTI","LU2362540622.SGD","CRSP","IE0002141913.USD","IE00B4R5TH58.HKD","MGX","NTLA","GILD"],"gpt_icon":1},{"id":"2522750884","title":"Neurogene files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2522750884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522750884?lang=en_us&edition=fundamental","pubTime":"2025-03-26 03:18","pubTimestamp":1742930338,"startTime":"0","endTime":"0","summary":"16:35 EDT Neurogene (NGNE) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522881034","title":"Neurogene price target lowered to $38 from $46 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881034?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:59","pubTimestamp":1742929142,"startTime":"0","endTime":"0","summary":"Baird analyst Joel Beatty lowered the firm’s price target on Neurogene (NGNE) to $38 from $46 and keeps an Outperform rating on the shares. The fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-price-target-lowered-to-38-from-46-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-price-target-lowered-to-38-from-46-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522291260","title":"Neurogene Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522291260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522291260?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:32","pubTimestamp":1742902320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NGNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 07:32 ET (11:32 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2522085674","title":"Neurogene Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522085674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522085674?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:33","pubTimestamp":1742851983,"startTime":"0","endTime":"0","summary":"Neurogene Inc reports results for the quarter ended December 31 - Earnings SummaryNeurogene Inc NGNE.OQ reported a quarterly adjusted loss of 99 cents per share for the quarter ended December 31, high","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q7201:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE"],"gpt_icon":0},{"id":"2522088469","title":"Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2522088469","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522088469?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:53","pubTimestamp":1742849638,"startTime":"0","endTime":"0","summary":"Neurogene Q4 Net Profit $(19.5)M Down From $2.4M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44465862/neurogene-q4-net-profit-19-5-m-down-from-2-4m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522263700","title":"BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522263700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522263700?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:38","pubTimestamp":1742848737,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC FilingMarch 24  - Neurogene Inc NGNE.O:NEUROGENE INC: FILES FOR MIXED SHELF OFFERING OF UP TO $300 MILLION - SEC FILINGSource text: [ID:n0001628280-25-014521]Further company coverage: NGNE.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q71D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522700424","title":"Neurogene Inc: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522700424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522700424?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:35","pubTimestamp":1742848557,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q71D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522707976","title":"BRIEF-Neurogene FY Net Income USD -75.144 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707976?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847045,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene FY Net Income USD -75.144 Million\n\n\nMar 24 (Reuters) - Neurogene FY operating income USD -82.605 million.\n\nFY operating expenses USD 83.53 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"gpt_icon":0},{"id":"2522707970","title":"Neurogene Inc - Regulatory Update on Ngn-401 Trial Plans Expected in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707970?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707942","title":"Neurogene Inc: Cash Runway Into Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707942?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707613","title":"Neurogene FY Operating Income USD -82.605 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707613?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX3DFE3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522707697","title":"Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707697?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA5TNLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"gpt_icon":0},{"id":"2522770718","title":"Press Release: Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522770718","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522770718?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:10","pubTimestamp":1742847000,"startTime":"0","endTime":"0","summary":"Remains on track to provide regulatory update on registrational trial plans with NGN-401 for Rett syndrome in the first half of 2025. Continues to expect to share additional interim clinical data from NGN-401 Phase 1/2 trial in the second half of 2025. Received PRIME designation for NGN-401 from the European Medicines Agency. Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced fourth quarter and full year 2024 financial results and highlighted recent corporate updates.Fourth Quarter 2024 and Recent Highlights, and Anticipated Milestones. -- Protocol amended and submitted to U.S. Food and Drug Administration . participants expected to be dosed during the first half of the year","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","LU0170899867.USD","NGNE","IE00BHPRN162.USD","LU1363072403.SGD","CMC","BK4139","BK4099","BK4006","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4604","LU0267386448.USD","BK4588","IE00B1BXHZ80.USD","TM","LU0149725797.USD","LU0971096721.USD","03160","LU0882574139.USD","BK4585"],"gpt_icon":0},{"id":"2521037934","title":"North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2521037934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521037934?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:02","pubTimestamp":1742551320,"startTime":"0","endTime":"0","summary":"The euphoria from the Federal Reserve's policy meeting didn't last long.Stock futures were lower Friday as attention shifted from the Fed to the prospect of further tariffs.Trump said in a social media post that the planned imposition of reciprocal tariffs on April 2 would be \"Liberation Day\" in the U.S.\"We maintain our view that the FOMC outcome was effectively a one-day move, with minimal legacy in terms of immediate direction. That said, we also view the FOMC outcome as a whole as nodding towards dovishness, but with numerous caveats,\" ING said.Quantum-computing stocks  are likely to be in focus after suffering steep falls on Thursday as investors appeared unimpressed by their contributions to Nvidia's Quantum Day at its GTC developers' event.The market also faces a test as an estimated $4.5 trillion in options contracts expire, which could increase volatility.FedEx fell 5.1% off hours after it cut its outlook for the year.Lennar management warned investors of a weak housing market.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US10Y.BOND","IRD","NVDD","FBLG","IMRX","USAU","XOMA","US30Y.BOND","ET","NVDS.UK","US2Y.BOND","US7Y.BOND","DXYN","DM","ADVM","NVDY","SNVD.UK","SMXT","NGNE","CCL","NVDL","GORV","US6M.BOND","JVA","BPTH","US3Y.BOND","PURE","FBRX","US5Y.BOND","3NVD.UK","BOLD","AFG","NVDU","2NVD.UK","MPU","US12M.BOND","NVD3.UK","NVIW.SI","OLMA","NVDS","IMNM","PRPH","NVDA","ATXI","NVD2.UK","ZBIO","CKPT","SGMA","NVDX"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGNE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-24","symbol":"NGNE","fiscalQuarterEnding":"2024/12","expectedEps":-1.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.99},{"market":"US","date":"2024-11-18","symbol":"NGNE","fiscalQuarterEnding":"2024/09","expectedEps":-1.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731906000000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2024-08-09","symbol":"NGNE","fiscalQuarterEnding":"2024/06","expectedEps":-1.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-1.09},{"market":"US","date":"2024-05-10","symbol":"NGNE","fiscalQuarterEnding":"2024/03","expectedEps":-1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":1},{"market":"US","date":"2024-03-18","symbol":"NGNE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGNE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGNE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.4286,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5714,"analysts":7,"updateTime":1719633600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGNE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGNE","date":"2025-04-17","current":-2.044108,"percent":0.977273,"low":-19.523035,"twenty":-11.997937,"median":-9.328916,"eighty":-4.961897,"high":-1.458307,"avg":-8.95624,"sd":3.856336,"marketCap":153602450},"quantilePoints":[{"date":"2023-12-29","current":-4.323556,"twenty":-4.185645,"median":-3.978778,"eighty":-3.916869,"marketCap":220311097},{"date":"2024-01-05","current":-5.423319,"twenty":-5.000527,"median":-4.624292,"eighty":-3.978778,"marketCap":276350648},{"date":"2024-01-12","current":-8.005373,"twenty":-7.157271,"median":-5.423319,"eighty":-4.323556,"marketCap":407921769},{"date":"2024-01-19","current":-7.59768,"twenty":-7.599292,"median":-7.086806,"eighty":-4.804734,"marketCap":387147382},{"date":"2024-01-26","current":-8.053188,"twenty":-7.611677,"median":-7.561189,"eighty":-4.985427,"marketCap":410358272},{"date":"2024-02-02","current":-7.741127,"twenty":-7.937424,"median":-7.577547,"eighty":-5.338761,"marketCap":394456888},{"date":"2024-02-09","current":-7.497015,"twenty":-7.980207,"median":-7.59013,"eighty":-6.388695,"marketCap":382017903},{"date":"2024-02-16","current":-7.549864,"twenty":-7.937424,"median":-7.577547,"eighty":-6.995453,"marketCap":384710880},{"date":"2024-02-23","current":-7.622846,"twenty":-7.894138,"median":-7.57503,"eighty":-7.129085,"marketCap":388429751},{"date":"2024-03-01","current":-7.819143,"twenty":-7.894138,"median":-7.588872,"eighty":-7.262969,"marketCap":398432234},{"date":"2024-03-08","current":-9.734292,"twenty":-8.024499,"median":-7.59768,"eighty":-7.381754,"marketCap":496020561},{"date":"2024-03-15","current":-8.697444,"twenty":-8.083388,"median":-7.629138,"eighty":-7.463796,"marketCap":443186933},{"date":"2024-03-22","current":-17.419498,"twenty":-9.10262,"median":-7.660596,"eighty":-7.498525,"marketCap":632623921},{"date":"2024-03-28","current":-17.433655,"twenty":-9.373408,"median":-7.741127,"eighty":-7.499532,"marketCap":633138041},{"date":"2024-04-05","current":-15.090764,"twenty":-9.721205,"median":-7.845567,"eighty":-7.510605,"marketCap":548051280},{"date":"2024-04-12","current":-13.565408,"twenty":-14.180505,"median":-7.97769,"eighty":-7.536275,"marketCap":492654915},{"date":"2024-04-19","current":-11.176509,"twenty":-13.912948,"median":-8.029281,"eighty":-7.549864,"marketCap":405897266},{"date":"2024-04-26","current":-10.571321,"twenty":-13.650346,"median":-8.053188,"eighty":-7.549864,"marketCap":383918661},{"date":"2024-05-03","current":-12.537284,"twenty":-13.442874,"median":-8.146303,"eighty":-7.558924,"marketCap":455316556},{"date":"2024-05-10","current":-11.764996,"twenty":-13.2542,"median":-9.074937,"eighty":-7.57352,"marketCap":427269365},{"date":"2024-05-17","current":-10.587696,"twenty":-13.13876,"median":-9.272492,"eighty":-7.576037,"marketCap":433830864},{"date":"2024-05-24","current":-9.887502,"twenty":-12.800854,"median":-9.44488,"eighty":-7.581574,"marketCap":405140389},{"date":"2024-05-31","current":-10.685033,"twenty":-12.52136,"median":-9.620612,"eighty":-7.588117,"marketCap":437819226},{"date":"2024-06-07","current":-11.771752,"twenty":-12.409114,"median":-9.810897,"eighty":-7.59013,"marketCap":482347539},{"date":"2024-06-14","current":-13.301826,"twenty":-12.457666,"median":-9.93146,"eighty":-7.59013,"marketCap":545042335},{"date":"2024-06-21","current":-9.842528,"twenty":-12.564112,"median":-9.93146,"eighty":-7.59617,"marketCap":403297579},{"date":"2024-06-28","current":-11.030474,"twenty":-12.52136,"median":-10.019377,"eighty":-7.599292,"marketCap":451973662},{"date":"2024-07-05","current":-11.397945,"twenty":-12.537284,"median":-10.188931,"eighty":-7.605739,"marketCap":467030798},{"date":"2024-07-12","current":-13.232134,"twenty":-12.537284,"median":-10.458961,"eighty":-7.622846,"marketCap":542186671},{"date":"2024-07-15","current":-13.48873,"twenty":-12.644595,"median":-10.463671,"eighty":-7.625363,"marketCap":552700705},{"date":"2024-08-02","current":-12.832984,"twenty":-12.76836,"median":-10.468381,"eighty":-7.627879,"marketCap":525831507},{"date":"2024-08-09","current":-11.578513,"twenty":-12.617767,"median":-10.579508,"eighty":-7.644992,"marketCap":474429562},{"date":"2024-08-16","current":-9.721942,"twenty":-12.533918,"median":-10.468381,"eighty":-7.659841,"marketCap":462832495},{"date":"2024-08-23","current":-9.22793,"twenty":-12.500388,"median":-10.20777,"eighty":-7.686769,"marketCap":439314055},{"date":"2024-08-30","current":-9.934831,"twenty":-12.3607,"median":-10.082175,"eighty":-7.732068,"marketCap":472967513},{"date":"2024-09-06","current":-9.383503,"twenty":-12.215183,"median":-10.030358,"eighty":-7.751697,"marketCap":446720414},{"date":"2024-09-13","current":-11.015654,"twenty":-12.198503,"median":-10.056266,"eighty":-7.799009,"marketCap":524422220},{"date":"2024-09-20","current":-11.343175,"twenty":-12.111032,"median":-10.20463,"eighty":-7.829713,"marketCap":540014556},{"date":"2024-09-27","current":-10.69359,"twenty":-12.018852,"median":-10.282823,"eighty":-7.883065,"marketCap":509089757},{"date":"2024-10-04","current":-12.12104,"twenty":-12.018852,"median":-10.468381,"eighty":-7.937424,"marketCap":577046353},{"date":"2024-10-11","current":-13.141817,"twenty":-12.215183,"median":-10.579508,"eighty":-7.980207,"marketCap":625642465},{"date":"2024-10-18","current":-14.443716,"twenty":-12.644595,"median":-10.678753,"eighty":-7.993293,"marketCap":687621999},{"date":"2024-10-25","current":-13.155463,"twenty":-12.975228,"median":-10.69616,"eighty":-8.014936,"marketCap":626292146},{"date":"2024-10-31","current":-11.938174,"twenty":-12.976568,"median":-10.764003,"eighty":-8.053188,"marketCap":568340632},{"date":"2024-11-08","current":-18.968977,"twenty":-13.201862,"median":-10.833215,"eighty":-8.053188,"marketCap":903056103},{"date":"2024-11-15","current":-10.699049,"twenty":-13.232134,"median":-10.867118,"eighty":-8.053188,"marketCap":509349629},{"date":"2024-11-22","current":-3.804354,"twenty":-13.201862,"median":-10.811892,"eighty":-8.005373,"marketCap":202570426},{"date":"2024-11-29","current":-7.081932,"twenty":-13.164743,"median":-10.73726,"eighty":-7.916284,"marketCap":377091628},{"date":"2024-12-06","current":-6.123936,"twenty":-13.144546,"median":-10.69616,"eighty":-7.738107,"marketCap":326081199},{"date":"2024-12-13","current":-6.220014,"twenty":-13.009618,"median":-10.678753,"eighty":-7.632912,"marketCap":331197071},{"date":"2024-12-20","current":-6.147607,"twenty":-12.971208,"median":-10.579508,"eighty":-7.59013,"marketCap":327341631},{"date":"2024-12-27","current":-6.711544,"twenty":-12.908645,"median":-10.50763,"eighty":-7.57654,"marketCap":357369573},{"date":"2025-01-03","current":-6.374574,"twenty":-12.853892,"median":-10.405691,"eighty":-7.549864,"marketCap":339426951},{"date":"2025-01-10","current":-5.995231,"twenty":-12.800672,"median":-10.212067,"eighty":-7.505069,"marketCap":319228040},{"date":"2025-01-17","current":-4.918377,"twenty":-12.651961,"median":-10.173232,"eighty":-7.427764,"marketCap":261888801},{"date":"2025-01-24","current":-4.346472,"twenty":-12.574112,"median":-10.030358,"eighty":-7.086806,"marketCap":231436615},{"date":"2025-01-31","current":-4.332524,"twenty":-12.537284,"median":-9.920586,"eighty":-6.842433,"marketCap":230693879},{"date":"2025-02-07","current":-6.50018,"twenty":-12.535901,"median":-9.842528,"eighty":-6.605719,"marketCap":346115092},{"date":"2025-02-14","current":-5.236411,"twenty":-12.52887,"median":-9.777894,"eighty":-6.491539,"marketCap":278823188},{"date":"2025-02-21","current":-4.829104,"twenty":-12.471907,"median":-9.750601,"eighty":-6.430271,"marketCap":257135289},{"date":"2025-02-28","current":-4.770518,"twenty":-12.349943,"median":-9.721942,"eighty":-6.303838,"marketCap":254015797},{"date":"2025-03-07","current":-4.672876,"twenty":-12.236804,"median":-9.661093,"eighty":-6.2189,"marketCap":248816643},{"date":"2025-03-14","current":-4.686825,"twenty":-12.214976,"median":-9.588204,"eighty":-6.130619,"marketCap":249559380},{"date":"2025-03-21","current":-4.24883,"twenty":-12.149292,"median":-9.555425,"eighty":-6.004158,"marketCap":226237461},{"date":"2025-03-28","current":-3.045755,"twenty":-12.12341,"median":-9.468113,"eighty":-5.45457,"marketCap":228870246},{"date":"2025-04-04","current":-1.92123,"twenty":-12.043093,"median":-9.418302,"eighty":-5.225252,"marketCap":144368903},{"date":"2025-04-11","current":-1.782154,"twenty":-12.004592,"median":-9.374415,"eighty":-5.034123,"marketCap":133918207},{"date":"2025-04-17","current":-2.044108,"twenty":-11.997937,"median":-9.328916,"eighty":-4.961897,"marketCap":153602450}],"updateTime":1745274103050}}}